Melhores podcasts sobre Gastrointestinal Cancer (2024)

1
Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors 59:21

14d ago59:21

59:21

Dr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for desmoid tumors and review novel options for targeted therapy.Por Neil Love, MD

1
S11 Ep30: SUNLIGHT QOL Data Show Positive Outcomes With T rifluridine-Tipiracil Plus Bevacizumab in CRC : With Joleen Hubbard, MD 10:38

1d ago10:38

10:38

In today’s episode, supported by Taiho Pharmaceutical, we had the pleasure of speaking with Joleen Hubbard, MD, about practice-changing updates to the colorectal cancer (CRC) treatment paradigm. Dr Hubbard is a medical oncologist at Allina Health Cancer Institute in Minneapolis, Minnesota. In our exclusive interview, Dr Hubbard discussed key effica…

1
S11 Ep29: Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD 20:23

2d ago20:23

20:23

In this episode of the Oncology Unplugged series, Chandler Park, MD, a genitourinary medical oncologist at Norton Cancer Institute in Louisville, Kentucky, hosted a conversation with Vivek Subbiah, MD, a medical oncologist and chief of Early-Phase Drug Development at Sarah Cannon Research Institute in Nashville, Tennessee. Dr Subbiah, an internatio…

1
Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing

3d ago

—

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: William Grady, MD While colorectal cancer is the second most common cause of cancer deaths, only a third of people between the ages of 45 and 75 are compliant with screening recommendations. However, cell-free DNA blood-based tests could become a new option for colorectal cancer screening. Dr. Peter Buc…

1
S11 Ep28: Liquid Biopsy Ushers in a New Era of NSCLC Biomarker Testing: With David R. Gandara, MD 11:29

4d ago11:29

11:29

In today’s episode, we had the pleasure of speaking with David R. Gandara, MD, about biomarker testing in lung cancer. Dr Gandara is the chief medical officer of the International Society of Liquid Biopsy, the co-director of the Center for Experimental Therapeutics in Cancer, and the senior advisor to the director at the University of California Da…

1
Decoding Bloating: Clinical Assessment and Therapeutic Approaches

5d ago

—

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Kyle Staller, MD, MPH Join Dr. Peter Buch as he speaks with Dr. Kyle Staller, Director of the Gastrointestinal Motility Laboratory at Mass General and Assistant Professor of Medicine at Harvard Medical School, about uncovering the cause of a patient’s bloating and determining how to manage it.…

1
Grappling with Gastroparesis: Key Management Strategies

5d ago

—

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Kyle Staller, MD, MPH The complexities of gastroparesis can make the disease difficult to diagnose and treat. To help us overcome these challenges, Dr. Kyle Staller joins Dr. Peter Buch to share his preferred strategies for managing patients with gastroparesis. Not only is Dr. Staller an Assistant Profe…

1
S11 Ep27: Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD 11:33

8d ago11:33

11:33

In today’s episode, we had the pleasure of speaking with Alan P. Venook, MD, about recent updates to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for gastrointestinal (GI) cancers. Dr Venook holds the Madden Family Distinguished Professorship in Medical Oncology and Translational Research and is a professor in the D…

1
Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies 20:40

9d ago20:40

20:40

In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including: 3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D The role of bispecific antibodies in R/R MM Safety considerations for patients while receiving a bispecific antibody Emerging…

1
S11 Ep26: Phase 1 Trials Provide Oncology Fellows With Valuable Clinical Research Experience: With Samuel A. Kareff, MD, MPH 14:08

11d ago14:08

14:08

In today’s episode, we had the pleasure of speaking with Samuel A. Kareff, MD, MPH, about the intersections between early-phase clinical research and meaningful mentorship experiences during oncology/hematology fellowship. Dr Kareff is a medical oncologist and hematologist at the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Hea…

1
Sickle Cell Awareness from the Patients and Experts with Maximal Being & Dr. Scott & Kyle | Part 1, Podcast 83 40:30

12d ago40:30

40:30

In this episode of the Maximal Being podcast, Jacky P discusses sickle cell disease with Dr. Scott Peslak and Kyle Smith. Dr. Scott explains that sickle cell is a genetic disorder affecting hemoglobin, leading to stiff red blood cells that can block blood flow and cause pain, organ damage, and other complications. Kyle, a sickle cell warrior, empha…

1
Recognizing and Addressing Burnout Among GI Providers

15d ago

—

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Brian E. Lacy, MD, PhD About 50 percent of gastrointestinal providers are experiencing some degree of burnout, which can lead to a variety of personal and professional challenges. Joining Dr. Peter Buch to discuss the signs of burnout and what you can do to mitigate them is Dr. Brian Lacy, lead author o…

1
Managing Pouchitis: A Review of the Updated AGA Guidelines

15d ago

—

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Edward L. Barnes, MD, MPH Tune in to learn about the newest clinical practice recommendations for pouchitis and inflammatory pouch disorders. Tune in to learn about the newest clinical practice recommendations for pouchitis and inflammatory pouch disorders. Tune in to learn about the newest clinical pra…

1
SIBO Solutions: A Guide to Recognition, Diagnosis, and Treatment

15d ago

—

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Eamonn Quigley, MD Small intestinal bacterial overgrowth (SIBO) is often overdiagnosed due to misconceptions about symptoms and inaccurate tests. Join Dr. Peter Buch and Dr. Eamonn Quigley as they explore considerations for knowing when and how to diagnose and treat SIBO. Dr. Quigley is the Chief of Gas…

1
S11 Ep25: FDA Approval Insights: Denileukin Diftitox in Relapsed/Refractory CTCL 8:17

15d ago8:17

8:17

In today’s episode, supported by Citius Pharmaceuticals, we had the pleasure of speaking with Francine Foss, MD, to discuss the FDA approval of denileukin diftitox-cxdl (Lymphir) for the treatment of patients with relapsed/refractory cutaneous T-cell lymphoma (CTCL) who have received 1 or more prior systemic therapies. Dr Foss is a professor of med…

1
S11 Ep24: How to Apply Research Developments in ALK-Positive NSCLC: With Chandler Park, MD, and Tejas Patil, MD 17:21

16d ago17:21

17:21

Dr Patil emphasized the significance of the phase 3 CROWN trial (NCT03052608), which compared lorlatinib (Lorbrena) with crizotinib (Xalkori) in patients with ALK-positive metastatic NSCLC. With a hazard ratio of 0.19 (95% CI, 0.13-0.27) for progression-free survival, the trial demonstrated lorlatinib’s superior intracranial control and long-term e…

1
Gastroenteropancreatic Neuroendocrine Tumors: Diagnosis, Findings, and Recommendations 28:28

16d ago28:28

28:28

In this episode, Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss important topics related to gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including: The diagnosis and typical presenting symptoms of GEP-NETs Findings from recent key phase III studies including NETTER-2 and CABINET Recommendations for treatment sequencing No…

1
S11 Ep23: Navigating Myelofibrosis: Updates for Community Hematologist Oncologists 25:38

18d ago25:38

25:38

In today’s episode, supported by Sobi, we had the pleasure of speaking with Aaron T. Gerds, MD, MS, and James K. McCloskey, MD, about myelofibrosis treatment advances. Dr Gerds is an assistant professor in the Department of Medicine in the School of Medicine, as well as a member of the Developmental Therapeutics Program at the Case Comprehensive Ca…

1
S11 Ep22: FDA Approval Insights: Vorasidenib in IDH1/2+ Grade 2 Astrocytoma and Oligodendroglioma 12:28

22d ago12:28

12:28

In today’s episode, supported by Servier Pharmaceuticals, we had the pleasure of speaking with Jennie W. Taylor, MD, MPH, about the FDA approval of vorasidenib (Voranigo) for patients with IDH-positive grade 2 astrocytoma or oligodendroglioma. Dr Taylor is an associate professor of clinical neurology at the University of California, San Francisco (…

1
Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database 12:47

25d ago12:47

12:47

Dr. Rick Greene discusses with Dr. Dana Dominguez the association of adjuvant chemoradiation in resected biliary cancer with improved overall survival compared to chemotherapy alone, as reported in her article, "Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database.” Article: Adjuvant Ch…

1
S11 Ep21: Updated VISION Trial Data Showcase the Efficacy of Tepotinib in MET + NSCLC: With Martin Dietrich, MD 11:59

25d ago11:59

11:59

In our exclusive interview, Dr Dietrich discussed key efficacy findings from the 18-month follow-up of the phase 2 VISION trial (NCT02864992), which evaluated the efficacy of tepotinib (Tepmetko) in patients with non–small cell lung cancer harboring MET exon 14 skipping mutations. Additionally, Dr Dietrich emphasized important safety considerations…

1
S11 Ep20: FDA Approval Insights: Perioperative Durvalumab for Resectable NSCLC 15:09

29d ago15:09

15:09

In today’s episode, supported by AstraZeneca, we had the pleasure of speaking with Sandip P. Patel, MD, and Brendon M. Stiles, MD, about the FDA approval of perioperative durvalumab (Imfinzi) for patients with resectable non–small cell lung cancer (NSCLC). Dr Patel is a professor of medicine in the Department of Medicine at the University of Califo…

1
S11 Ep19: Immunotherapy Advances Expand the SCLC Treatment Paradigm: With Chandler Park, MD, and Tejas Patil, MD 15:18

1M ago15:18

15:18

In part 2 of this 3-part Oncology Unplugged series, Chandler Park, MD, a genitourinary medical oncologist at Norton Cancer Institute in Louisville, Kentucky, and Tejas Patil, MD, an assistant professor of medical oncology at the University of Colorado School of Medicine in Aurora, discussed the evolving small cell lung cancer (SCLC) treatment parad…

1
ESMO 2024 Congress Highlights in Gynecologic Cancer: New Data Informing Treatment of Ovarian, Endometrial, and Cervical Cancers 30:45

1M ago30:45

30:45

In this episode, listen to Ana Oaknin, MD, PhD and Alexandra Leary, MD, PhD, share their clinical insights and takeaways on key updates and new data presented for ovarian, endometrial, and cervical cancer at the ESMO 2024 annual congress including: Phase III PRIMA/ENGOT-OV26/GOG-3012 Final OS Results: Niraparib as First-Line Maintenance in Advanced…

1
S11 Ep18: Board Review Resources 2024 15:25

1M ago15:25

15:25

Two Onc Docs, hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to providing current and future oncologists and hematologists with the knowledge they need to ace their boards and deliver quality patient care. Dr Armstrong is a hematologist/oncologist and assistant professor of clinical medicine at Indiana University…

1
A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance 32:48

1M ago32:48

32:48

In this episode, listen to Matthew S. Davids, MD, MMSc, and Lindsey Roeker, MD, discuss BTK inhibitor resistance and how it shapes treatment choices for patients with CLL, including: Contemporary treatment paradigms for patients with CLL Safety and efficacy of current regimens Molecular testing, including when and how to test for BTK inhibitor res…

1
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster

1M ago

—

Host: Jennifer Caudle, DO Guest: A. Mark Fendrick, MD Approximately 40 percent of the eligible U.S. population are not up to date with their colorectal cancer (CRC) screenings, which inspired this study that was presented at Digestive Disease Week (DDW) 2024 to help eliminate the colonoscopy backlog with stool-based CRC screening options. To learn …

1
S11 Ep17: How Luspatercept Could Shake Up MDS Management—With Rory Shallis, MD 13:01

1M ago13:01

13:01

In today’s episode, we had the pleasure of speaking with Rory Shallis, MD, an assistant professor of medicine and hematology at Yale School of Medicine, part of Yale New Haven Health in Connecticut. Shallis sat down with us to share some of the research that has been generated in myelodysplastic syndrome (MDS) over the past year or so, touching on …

1
S11 Ep16: FDA Approval Insights: Afami-Cel for Pretreated, Unresectable or Metastatic Synovial Sarcoma 13:08

1M ago13:08

13:08

Dr Warner discusses the FDA approval of afami-cel for patients with advanced synovial sarcoma and key findings from the pivotal SPEARHEAD-1 trial.Por OncLive® On Air

1
Caregiving for Your Loved One with Cancer 51:52

1M ago51:52

51:52

- Definition of a Caregiver- What Research Tells Us About Caregivers’ Well Being- Caregiving for an Older Adult- Caregiving for a Younger Adult- Caregiving for a Friend- Caregivers for Cancer Survivors- Couples, Partners, Siblings & Friends- Family, Partner & Friend Communication- Care Coordination: Challenges & Tips- Stresses on Family, Partners &…

1
Caregiving for Your Loved One with Cancer 51:52

1M ago51:52

51:52

- Definition of a Caregiver- What Research Tells Us About Caregivers’ Well Being- Caregiving for an Older Adult- Caregiving for a Younger Adult- Caregiving for a Friend- Caregivers for Cancer Survivors- Couples, Partners, Siblings & Friends- Family, Partner & Friend Communication- Care Coordination: Challenges & Tips- Stresses on Family, Partners &…

1
Caregiving for Your Loved One with Cancer 51:52

1M ago51:52

51:52

- Definition of a Caregiver- What Research Tells Us About Caregivers’ Well Being- Caregiving for an Older Adult- Caregiving for a Younger Adult- Caregiving for a Friend- Caregivers for Cancer Survivors- Couples, Partners, Siblings & Friends- Family, Partner & Friend Communication- Care Coordination: Challenges & Tips- Stresses on Family, Partners &…

1
Caregiving for Your Loved One with Cancer 51:52

1M ago51:52

51:52

- Definition of a Caregiver- What Research Tells Us About Caregivers’ Well Being- Caregiving for an Older Adult- Caregiving for a Younger Adult- Caregiving for a Friend- Caregivers for Cancer Survivors- Couples, Partners, Siblings & Friends- Family, Partner & Friend Communication- Care Coordination: Challenges & Tips- Stresses on Family, Partners &…

1
Caregiving for Your Loved One with Cancer 51:52

1M ago51:52

51:52

- Definition of a Caregiver- What Research Tells Us About Caregivers’ Well Being- Caregiving for an Older Adult- Caregiving for a Younger Adult- Caregiving for a Friend- Caregivers for Cancer Survivors- Couples, Partners, Siblings & Friends- Family, Partner & Friend Communication- Care Coordination: Challenges & Tips- Stresses on Family, Partners &…

1
Advancements in Colon Cancer Screening and Prevention with Doc Mok | Podcast 82 17:45

1M ago17:45

17:45

Doc Mok discusses advancements in colon cancer screening, emphasizing the importance of early detection. He highlights a study from the New England Journal of Medicine on blood-based tests and a 20-year cohort study by Charlotte Skriver. Topics - Blood-Based Tests for Colon Cancer Screening - Stool-Based DNA Tests and Colonoscopy - Aspirin and Canc…

1
Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers 2:14:52

1M ago2:14:52

2:14:52

Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco…

1
S11 Ep15: Thomas and Lukas Highlight Updates in Brain Cancer from the 2024 ASCO Annual Meeting 15:28

1M ago15:28

15:28

Welcome to OncLive On Air®! I’m your host today, Ashling Wahner. OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances…

1
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors 59:19

1M ago59:19

59:19

Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.Por Neil Love, MD

1
S11 Ep14: Park and Patil Explore Advances in EGFR + NSCLC From ASCO 2024 19:42

1M ago19:42

19:42

In Oncology Unplugged, a podcast series from MedNews Week, host Chandler Park, MD, a genitourinary medical oncologist at the Norton Cancer Institute in Louisville, Kentucky, sits down with Tejas Patil, MD, an assistant professor of medicine-medical oncology at the University of Colorado School of Medicine - Anschutz Medical Campus in Aurora. In thi…

1
S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care 19:35

2M ago19:35

19:35

Por CURE Talks Cancer

1
S11 Ep13: FDA Approval Insights: Epcoritamab in Relapsed/Refractory Follicular Lymphoma 9:02

2M ago9:02

9:02

Welcome to OncLive On Air®! I’m your host today, Ashling Wahner. OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances…

1
Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers 1:00:58

2M ago1:00:58

1:00:58

Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.Por Neil Love, MD

1
S11 Ep12: Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress 11:49

2M ago11:49

11:49

In today’s episode, we invited experts from across oncology specialties to discuss the abstracts and presentations they are most looking forward to seeing at the 2024 ESMO Congress. Emre Yekedüz, MD, an associate professor of medical oncology at Ankara University in Turkey and a research fellow at Dana-Farber Cancer Institute in Boston, Massachuset…

1
Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma 1:15:13

2M ago1:15:13

1:15:13

Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas.Por Neil Love, MD

1
Current Perspectives on Cancer Survivorship 55:47

2M ago55:47

55:47

- Overview of Cancer Survivorship- Managing Post Treatment Side Effects/Late Effects- Quality-of-Life Concerns- Fear of Recurrence- Finding Your New Normal- The Importance of Treatment Summaries and Encounter Notes- Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns- Guidelines to Prepare f…

1
Current Perspectives on Cancer Survivorship 55:47

2M ago55:47

55:47

- Overview of Cancer Survivorship- Managing Post Treatment Side Effects/Late Effects- Quality-of-Life Concerns- Fear of Recurrence- Finding Your New Normal- The Importance of Treatment Summaries and Encounter Notes- Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns- Guidelines to Prepare f…

1
Current Perspectives on Cancer Survivorship 55:47

2M ago55:47

55:47

- Overview of Cancer Survivorship- Managing Post Treatment Side Effects/Late Effects- Quality-of-Life Concerns- Fear of Recurrence- Finding Your New Normal- The Importance of Treatment Summaries and Encounter Notes- Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns- Guidelines to Prepare f…

1
Current Perspectives on Cancer Survivorship 55:47

2M ago55:47

55:47

- Overview of Cancer Survivorship- Managing Post Treatment Side Effects/Late Effects- Quality-of-Life Concerns- Fear of Recurrence- Finding Your New Normal- The Importance of Treatment Summaries and Encounter Notes- Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns- Guidelines to Prepare f…

1
Current Perspectives on Cancer Survivorship 55:47

2M ago55:47

55:47

- Overview of Cancer Survivorship- Managing Post Treatment Side Effects/Late Effects- Quality-of-Life Concerns- Fear of Recurrence- Finding Your New Normal- The Importance of Treatment Summaries and Encounter Notes- Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns- Guidelines to Prepare f…

1
SSO2024 Abstract: Lower Social Support Predicts Higher Cortisol for Breast Cancer Patients in Disadvantaged Neighborhoods 15:45

2M ago15:45

15:45

Dr. Rick Greene discusses with Dr. Alexandra Hernandez the role of social support and neighborhood disadvantage on cortisol, a physiologic marker of stress in patients with breast cancer, as reported at the 2024 SSO Meeting in her abstract, "Lower Social Support Predicts Higher Cortisol for Breast Cancer Patients in Disadvantaged Neighborhoods.”…

Podcasts que valem a pena ouvir

Podcasts sobre Gastrointestinal Cancer

Podcasts que valem a pena ouvir

Guia rápido de referências